Evidence map›Paper›PMID 28352364›Full record

ArticleExperimental and therapeutic medicine2017

2,4,6-Trimethyl-

Elżbieta Grześk, Katarzyna Szadujkis-Szadurska, Elżbieta Bloch-Bogusławska, Michał Wiciński, Bartosz Malinowski, Sylwia KołTan, Barbara Tejza, Maciej Pujanek, Grzegorz GrześK

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Elżbieta GrześkDepartment of Pediatrics, Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Katarzyna Szadujkis-SzadurskaDepartment of Pharmacology and Therapeutics, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Elżbieta Bloch-BogusławskaDepartment of Forensic Medicine, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Michał WicińskiDepartment of Pharmacology and Therapeutics, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Bartosz MalinowskiDepartment of Pharmacology and Therapeutics, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Sylwia KołTanDepartment of Pediatrics, Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Barbara TejzaDepartment of Pediatrics, Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Maciej PujanekDepartment of Pharmacology and Therapeutics, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Grzegorz GrześKDepartment of Pharmacology and Therapeutics, Collegium Medicum, Nicolaus Copernicus University, PL-85-094 Bydgoszcz, Poland.
Nicolaus Copernicus University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been demonstrated that 2,4,6-trimethyl-

Indexed as

lipopolysaccharidesm-3M3FBSphenylephrinephospholipase Cvasopressin

Identifiers

PMID28352364
PMCPMC5348699
OpenAlexW2562486602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.